/ /

ophthalmology

European Commission approves adalimumab for paediatric uveitisThe European Commission has approved adalimumab (Humira, AbbVie) as the first biologic treatment for chronic non-infectious anterior uveitis in paediatric patients from 2 years of age who have had an inadequate response to conventional therapy.
NC ODs say laser privileges will expand access to care
What does 2017 have in store for ophthalmology?In preparing for the new year, Editorial Advisory Board members of Ophthalmology Times weighed in on a few questions about their predictions for how 2017 will impact ophthalmology as a specialty.
16 most popular stories of 2016
16 most popular stories of 2016Here is your roundup of what made top news in 2016!
How has ophthalmology changed in 2016?
How has ophthalmology changed in 2016?As the end of the year approaches, we wanted to take a look back at the predictions our Editorial Advisory Board members made for 2016 and see how far we’ve come in the last 12 months.
Giant cell arteritis treatment expeditedThe US Food and Drug Administration (FDA) is expediting its review of a new potential treatment for giant cell arteritis, a rare inflammatory disease that can cause permanent vision loss, Roche has announced.
Dyslexia: What you need to know
Dyslexia: What you need to knowMultiple issues may underlie a child's difficulty with reading proficiency, including poor early language development, inadequate instruction, insufficient reading practice, lack of background knowledge, and intellectual disability. In some children, however, the problem is the specific learning disability called dyslexia.
Fundus imaging results promising for early Alzheimer’s diagnosisStudies in mice suggest that a technology based on topical endoscope fundus imaging could allow early diagnosis of Alzheimer’s disease, researchers have said.
Experience with a novel Nd:YAG laserThe Nd:YAG laser plays a key part in ophthalmology. However, it is important to select a device that enables the best treatment results using lower energy and fewer shots
Wavefront-guided PRK after CXL for keratoconusTechnique targets the main cause of vision degradation and a large clinical series finds positive results.